Results 211 to 220 of about 22,830 (226)

Recent Advances in Targeting ROS1 in Lung Cancer

Journal of Thoracic Oncology, 2017
Alice Shaw, Jessica J Lin
exaly  

ROS1 as a ‘druggable’ receptor tyrosine kinase: lessons learned from inhibiting the ALK pathway

Expert Review of Anticancer Therapy, 2012
Sai-Hong Ou, Yun Yen
exaly  

ROS1 Gene Rearrangements Are Associated With an Elevated Risk of Peridiagnosis Thromboembolic Events

Journal of Thoracic Oncology, 2019
Terry Ng, Robert C Doebele, Anastasios Dimou   +2 more
exaly  

Structural insight into selectivity and resistance profiles of ROS1 tyrosine kinase inhibitors

Proceedings of the National Academy of Sciences of the United States of America, 2015
Alexander Drilon, Brian Druker, Christopher Eide   +2 more
exaly  

Novel targets in non-small cell lung cancer: ROS1 and RET fusions.

Oncologist, 2013
Alice Shaw, Justin F Gainor
exaly  

Multicenter Evaluation of a Novel ROS1 Immunohistochemistry Assay (SP384) for Detection of ROS1 Rearrangements in a Large Cohort of Lung Adenocarcinoma Patients

Journal of Thoracic Oncology, 2019
Nicolas Piton, Charles Marquette, Jonathan Benzaquen   +2 more
exaly  

ROS1 Immunohistochemistry Among Major Genotypes of Non–Small-Cell Lung Cancer

Clinical Lung Cancer, 2015
Theresa A Boyle, Fred Hirsch, Yasushi Yatabe   +2 more
exaly  

Testing for ROS1 in non-small cell lung cancer: a review with recommendations

Virchows Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medizin, 2016
Erik Thunnissen, Lukas Bubendorf
exaly  

CD74-ROS1 G2032R mutation transcriptionally up-regulates Twist1 in non-small cell lung cancer cells leading to increased migration, invasion, and resistance to crizotinib

Cancer Letters, 2018
Daiying Zuo, Zengqiang Li, Yingliang Wu
exaly  

ROS1 fusions in cancer: a review

Future Oncology, 2016
Arnaud Uguen, Marc De Braekeleer
exaly